A Phase II Study of Pembrolizumab (MK3475) with and without Bevacizumab
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Dana-Farber Cancer Institute
Start Date
June 1, 2015
End Date
May 31, 2019
Administered By
Duke Cancer Institute
Awarded By
Dana-Farber Cancer Institute
Start Date
June 1, 2015
End Date
May 31, 2019